Fluid AI Medical's Origin Device Gains FDA Clearance for Postoperative Monitoring

Sep 24, 2025
Fluid AI Medical has received FDA 510(k) clearance for its Origin device, a real-time postoperative monitoring system, as announced in a press release.

Fluid AI Medical has received FDA 510(k) clearance for its Origin device, a real-time, bedside monitoring system for surgical effluent in postoperative settings, announced in a press release. The Origin system can function independently or integrate with Stream Care, the company's AI-assisted surgical suite.

The clearance marks a significant step for Fluid AI Medical, enabling the company to expand its market reach across North America, Europe, and the Middle East. The Origin device provides continuous monitoring, transforming intermittent measurements into real-time data, which can help clinicians detect subtle biochemical changes that may indicate recovery progress or potential complications.

While the Origin system is not yet intended to diagnose postoperative complications in the U.S., its continuous sensing capabilities contribute to Fluid AI Medical's predictive models, paving the way for more proactive patient care. The company is backed by strategic collaborations with government agencies and global healthcare providers, further supporting its mission to enhance postoperative recovery through data-driven insights.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.